Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Melanoma × Isotretinoin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Medulloblastoma 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myelomonocytic, Juvenile 2 HIV Infections 2 Burkitt Lymphoma 2 Acquired Immunodeficiency Syndrome 2 AIDS-Related Complex 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Uterine Cervical Diseases 1 Tumor Virus Infections 1 Thrombocytopenia 1 Sezary Syndrome 1 Rhabdoid Tumor 1 Recurrence 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pinealoma 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1

Interventions

aldesleukin 61 Cyclophosphamide 43 fludarabine phosphate 28 fludarabine 27 Interleukin-2 22 incomplete Freund's adjuvant 21 Ipilimumab 15 Specimen Handling 13 Magnetic Resonance Spectroscopy 12 MART-1 Antigen 12 CTLA-4 Antigen 12 sargramostim 11 montanide ISA 51 11 Biopsy 11 Sorafenib 10 Filgrastim 10 Nivolumab 9 pembrolizumab 8 Interferon-alpha 8 trametinib 7 dabrafenib 7 Sirolimus 7 Bevacizumab 7 temsirolimus 6 Temozolomide 5 Introns 5 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 5 cediranib 4 cabozantinib 4 Whole-Body Irradiation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00025012 2013-06-19

Isotretinoin in Preventing Skin Cancer

National Cancer Institute (NCI)

Phase NA Completed

Carcinoma, Basal Cell, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡